Investing.com - Edwards Lifesciences (NYSE: EW) reported fourth quarter EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35B versus the consensus estimate of $1.33B.
Edwards Lifesciences's stock price closed at $76.74. It is up 11.77% in the last 3 months and down -29.19% in the last 12 months.
Edwards Lifesciences saw 0 positive EPS revisions and 21 negative EPS revisions in the last 90 days. See Edwards Lifesciences's stock price’s past reactions to earnings here.
According to InvestingPro, Edwards Lifesciences's Financial Health score is "great performance".
Check out Edwards Lifesciences's recent earnings performance, and Edwards Lifesciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar